Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab.

导出原文传递

翻译打印收藏纠错

作者： Jessica L,Sandy ^[1] ; Peter J,Simm ^[2] ; Andrew,Biggin ^[3] ; Christine P,Rodda ^[4] ; Christie-Lee,Wall ^[1] ; Aris,Siafarikas ^[5] ; Craig F,Munns ^[4]

作者单位： Institute of Endocrinology and Diabetes, Children's Hospital at Westmead, Sydney, New South Wales, Australia. ^[1] Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia. ^[2] Centre for Hormone Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia. ^[3] Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia. ^[4] Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia. ^[5] Australian Institute for Musculoskeletal Research, Melbourne, Victoria, Australia. ^[6] Department of Endocrinology and Diabetes, Perth Children's Hospital, Perth, Western Australia, Australia. ^[7] Division of Paediatrics, Medical School and Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia. ^[8] Institute for Health Research, University of Notre Dame, Fremantle, Western Australia, Australia. ^[9] Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. ^[10] Department of Endocrinology and Diabetes, Queensland Children's Hospital, Brisbane, Queensland, Australia. ^[11]

关键词 bone health monoclonal antibody rickets

主题词成年人(Adult);儿童(Child);女(雌)性(Female);成纤维细胞生长因子(Fibroblast Growth Factors);人类(Humans);疼痛(Pain);生活质量(Quality of Life)

DOI 10.1111/jpc.15976

PMID 35426466

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交